IntelliSep Sepsis Test

Rapid antibiotic susceptibility testing diagnostic system delivering results in hours instead of days for sepsis patients. Enables timely clinical intervention and appropriate antimicrobial selection.

Digital PCR-based test kit for rapid detection of pathogens and antibiotic resistance genes associated with sepsis. Provides comprehensive pathogen identification from blood samples within 2-3 hours.

Procalcitonin test kit using fluorescence immunochromatography for rapid detection of bacterial infections and sepsis risk assessment. This point-of-care diagnostic enables quick patient stratification in clinical settings with results available within minutes, supporting early intervention in acute care environments.

Biomarker test for sepsis risk assessment that detects elevation earlier than CRP and PCT markers. Enables earlier clinical intervention in sepsis management.

Multiplex test panel for detecting bacterial infection markers. Enables rapid assessment of bacterial sepsis and infection status through simultaneous analyte detection.

Immunoassay for procalcitonin measurement in sepsis and infection diagnosis. Supports antibiotic stewardship decisions.

Comprehensive in-vitro systems for pathogen detection and infectious disease identification. Accredited diagnostic solutions for clinical microbiology laboratories.

An in vitro diagnostic medical device that quantifies procalcitonin (PCT) in human serum using fluoroimmunoassay (FIA) to aid in the diagnosis of bacterial infection and sepsis. The test provides quantitative results within 15-20 minutes with a detection range of 0.1-50 ng/mL, enabling early diagnosis of localized infection, systemic infection (sepsis), septic shock, and bacterial infection confirmation. It offers high accuracy and correlation with comparative products.

Rapid home test kit for screening of common infection markers in blood or bodily fluid samples. Enables early detection and identification of potential infections. ISO 9001:2015 and ISO 13485:2016 certified for clinical use.

Rapid test device for qualitative detection of procalcitonin in clinical specimens. Used for assessment of bacterial infection and sepsis risk stratification.

An in vitro diagnostic immunochromatographic lateral-flow assay for the semi-quantitative measurement of human soluble Toll-like receptor 2 (sTLR2) in plasma, used as a biomarker for sepsis and other inflammatory conditions. The test delivers results in 10 minutes from a 20µL plasma or serum sample. Each kit contains 10 test devices and uses proprietary sTLR2 monoclonal antibodies. The assay is UKCA certified for clinical use in Great Britain and is developed and manufactured in the UK according to ISO13485 quality standards.

Rapid diagnostic assays for CRP, PCT, and SAA that enable physicians to quickly perform differential diagnosis between bacterial and viral infections directly at the patient's bedside. Vital for antibiotic stewardship and sepsis management.